SCOURBAN

Main information

  • Trade name:
  • SCOURBAN ORAL ANTI-DIARRHOEAL SUSPENSION
  • Pharmaceutical form:
  • ORAL SOLUTION/SUSPENSION
  • Units in package:
  • 100mL, 500mL, 2L, 5L
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • BAYER AUSTRALIA

Documents

Localization

  • Available in:
  • SCOURBAN ORAL ANTI-DIARRHOEAL SUSPENSION
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CALF | CAT | DOG | HORSE | BEEF CALF | BITCH | BOVINE | CALF - PODDY | CALF - PREWEANING | CALF - SUCKER | CASTRATE | CAT - QUEE
  • Therapeutic area:
  • antibiotic
  • Therapeutic indications:
  • BACTERIAL TOXIN | ELECTROLYTE REPLACEMENT | GASTRO ENTERITIS | PNEUMONIA | REDUCTION OF INTESTINAL MOTILITY | SCOURS | BACTERIAL PNEUMONIA | SELENIUM RESPONSIVE SCOURS
  • Product summary:
  • An aid in the prevention and treatment of bacterial diarrhoea in horses, calves, dogs and cats.DO NOT USE in lactating or pregnant cattle

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered and available
  • Authorization number:
  • 36026/100547
  • Authorization date:
  • 10-02-2015
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

Company Name:

BAYER AUSTRALIA

LTD

(ANIMAL HEALTH)

Product Name:

SCOURBAN ORAL ANTI-DIARRHOEAL SUSPENSION

eLabel Application

No:

DC12-62114253E17

APVMA Approval

No:

36026/100547

Label Name:

SCOURBAN ORAL ANTI-DIARRHOEAL SUSPENSION

Signal Headings:

PRESCRIPTION ANIMAL REMEDY

KEEP

OF REACH OF CHILDREN

FOR ANIMAL TREATMENT ONLY

Constituent

Statements:

54 mg/30ml NEOMYCIN SULFATE

182 mg/30ml STREPTOMYCIN

STREPTOMYCIN SULFATE

0.95 mg/30ml HYOSCINE AS HYOSCINE HYDROBROMIDE

159.6 mg/30ml PECTIN

5.9 mg/30ml CALCIUM AS CALCIUM GLUCONATE

57 mg/30ml POTASSIUM

POTASSIUM CHLORIDE

1.77 mg/30ml MAGNESIUM AS MAGNESIUM SULFATE

133 mg/30ml SODIUM AS SODIUM CHLORIDE

1065 mg/30ml SULFADIMIDINE

1065 mg/30ml SULFADIAZINE

{Also Contains)

627 mg/30ml GLYCINE

g/30ml KAOLIN CLAY

RLP

APPROVED

Claims:

An aid in the prevention and treatment of bacterial diarrhoea in horses, calves, dogs and

cats.

Directions for Use:

Restraints:

For the treatment

gastroenteritis and scour/pneumonia complex caused by sensitive

bacterial organisms. For restoring electrolyte loss, reducing intestinal motility and

elimination

bacterial toxins.

100mL

500mL

DO NOT USE

lactating or pregnant cattle.

Contraindications:

\ Precautions:

Dosage and

Administration:

General Directions:

Withholding

Periods:

Trade Advice:

First Aid

Instructions:

\ First Aid Warnings:

Environmental

Statements:

Disposal:

This product is contraindicated for use

animals with known sulfonamide sensitivity,

damage

blood dyscrasias.

SHAKE WELL BEFORE USE

For oral use only. Treat twice daily

Small animals 2mU3kg Bwt

Calves and horses

30ml/25kg

When treating salmonellosis and bacterial pneumonias continue treatment for a minimum

5 days.

MEAT: (horses

calves): DO NOT USE less than 14 days before slaughter for human

consumption.

MILK: (cattle): DO NOT USE in lactating or pregnant cattle.

Any variation by the prescribing veterinarian to the allowed dose, frequency, duration,

route, disease or target species may require extending the approved withholding period.

TRADE ADVICE

EXPORT SLAUGHTER INTERVAL (ESI):

ESI has not been

established for this product.

Note-observing

the meat withholding

period may not

sufficient

mitigate potential risks to export trade.

Trade advice should be sought from Bayer Australia Limited on 1800 678 368 before using

this product.

If poisoning occurs, contact a doctor or Poiso

Information Centre. Phone Australia

131126

Additional

formation is listed

the Material Safety Data Sheet.

OOmL

, 500mL] packs

Wrap

paper and place

garbage.

[2L, 5L] packs

Triple or

referably) pressure rinse into the medicated suspension. Do not dispose

undiluted chemicals on-site. Return clean container for recycling where this is an option

for disposal at a landfill authorized to accept that waste. If neither of these options are

available, bu

the container below 500

a disposal pit specifically marked and set up

for this purpose clear of waterways, vegetation and roots. Empty containers should not be

burned.

Storage:

Store below 25

(air conditioning).

3-11-2018

Janssen Issues Voluntary Nationwide Recall for one lot of ORTHO-NOVUM 1/35 and two lots of ORTHO-NOVUM 7/7/7 Due to Incorrect Veridate Dispenser Instructions

Janssen Issues Voluntary Nationwide Recall for one lot of ORTHO-NOVUM 1/35 and two lots of ORTHO-NOVUM 7/7/7 Due to Incorrect Veridate Dispenser Instructions

Janssen Pharmaceuticals, Inc. has initiated a voluntary recall of one lot of ORTHO-NOVUM 1/35 (norethindrone / ethinyl estradiol) Tablets and two lots of ORTHO-NOVUM 7/7/7 (norethindrone / ethinyl estradiol) Tablets to the pharmacy level. The patient information provided inside affected packages of ORTHO-NOVUM does not include the appropriate instructions for the Veridate dispenser.

FDA - U.S. Food and Drug Administration

There are no news related to this product.